ライフサイエンスコーパス: PBX1

1 imerize with pre-B-cell leukemia homeobox-1 (Pbx1).

2 pre-B-cell leukemia transcription factor-1 (PBX1).

3 ssion that includes the transcription factor Pbx1.

4 binding to the common heterodimeric partner Pbx1.

5 s1, decreasing its stability by sequestering Pbx1.

6 g KIX and bone marrow immortalization by E2A-PBX1.

7 be activated cooperatively by Klf4 and Meis2/Pbx1.

8 eins but not by the leukemic oncoprotein E2a-Pbx1.

9 t completely abrogate binding of E2A and E2A-PBX1.

10 evelopment more severely than single loss of Pbx1.

11 Wnt16 has been shown to be targeted by E2A-Pbx1.

12 g but independent of direct interaction with PBX1.

13 harbored within the PBX1 homeodomain of E2A-PBX1.

14 e homeodomain proteins, which includes human Pbx1.

15 n factors, including Tbx3, Gata5, Prdm1, and Pbx1.

16 conditional transformation properties on E2A-PBX1.

17 d deletions and loss of function variants in PBX1.

18 Pbx1/2 mutants have three salient molecular phenotypes o

19 ations/deletions in the PBX homeobox 1 gene (PBX1), a gene known to have a crucial role in kidney dev

20 Pbx1, a homeodomain transcription factor that was origin

21 In this study, we have identified Pbx1, a proto-oncogene in hematopoietic malignancy, as a

22 reviously unappreciated pathway in which E2A-PBX1 acts in concert with RUNX1 to enforce transcriptome

23 osteocalcin and Bsp promoters revealed that Pbx1 acts through a Pbx-binding site that is required to

24 Hoxd3(-/-) compound mutants, suggesting that Pbx1 acts together with multiple Hox proteins in the dev

25 hat decreasing Pbx2 dosage in the absence of Pbx1 affects axial development more severely than single

26 (SLC19A1, an MTX uptake transporter) in E2A-PBX1 ALL, significantly higher expression of breast canc

27 ges of differentiation, similar to human E2A-PBX1 ALL.

28 rs, including Atoh1, Gfi1, Pou4f3, Gata3 and Pbx1, all of which physically interact with Six1.

29 Functional studies validated Sprouty2 and PBX1, among others, as FoxO-regulated mediators of endot

30 iral transcription whereas overexpression of PBX1 and a PBX1-associated protein, PREP1, enhanced vira

31 diverse pathways, including LGALS3BP, KDM2B, PBX1 and BBS2, among others.

32 posterior HOX protein, HoxA9, complexed with Pbx1 and DNA, which reveals that the posterior Hox hexap

33 We demonstrate that Pbx1 and Emx2 bind in vivo to a conserved sequence upstr

34 bx1;Emx2 genetic interaction by showing that Pbx1 and Emx2 can bind specific DNA sequences as heterod

35 a analysis, we provide new insight into TCF3-PBX1 and ETV6-RUNX1 acute lymphoblastic leukemia.

36 Pbx1 and Hox11 genetically interact in spleen formation

37 n spleen mesenchymal cells, which co-express Pbx1 and Hox11.

38 Chromatin-associated Pbx1 and Hoxa10 were present at osteoblast-related gene

39 Thus, our results reveal novel roles for PBX1 and its transcriptional network in mDAn development

40 ites can be cooperatively activated by Meis2/Pbx1 and Klf4, dependent primarily on recruitment by Klf

41 rogenitors exhibit elevated levels of HoxA9, Pbx1 and Meis1, exaggerated HoxA9-Pbx1-Meis1 activity, a

42 erior HOXA9 protein with its TALE cofactors, PBX1 and MEIS1.

43 We show that the Pbx1 and Meis2 homeodomain proteins interact with Klf4 a

44 Notably, PBX1 and NFE2L1 levels are severely reduced in dopaminer

45 for B-cell maturation and oncogenesis by E2A-PBX1 and occurs through conserved PhiXXPhiPhi motifs (wi

46 Moreover, Pbx1 and Oct-1, as well as Prep1 and Oct-1, form functio

47 In this study, we first uncover that Pbx1 and Pbx2 are co-expressed in the lateral plate and

48 tion, Pax6 expression becomes dependent upon Pbx1 and Pbx2 function.

49 In addition, analysis of Pbx1 and Pbx2 knockout mice demonstrates that, during pa

50 In the absence of Pbx1 and Pbx3 function, Hox-dependent programs are lost

51 oles recently established for family members Pbx1 and Pbx3.

52 ole of two developmentally critical factors (Pbx1 and Prep-1) in the regulation of homeostasis in the

53 demonstrating that the homeodomain proteins PBX1 and PREP1 are cellular factors involved in Moloney

54 icating a multilayered interplay between E2A-PBX1 and RUNX1.

55 conserved binding sites for Klf4, Meis2, and Pbx1 and show that at least some of these genes can be a

56 bly lower levels than comparable isoforms of Pbx1 and/or Pbx3 in embryonic tissues.

57 repressor of pre-B-cell leukemia homeobox 1 (PBX1) and is also known to regulate estrogen receptor fu

58 pre B-cell leukemia transcription factor 1 (PBX1) and PBX-regulating protein-1 (PREP1), function as

59 late cortical patterning (CoupTFI, Pax6, and Pbx1), and analysis of enhancer activity in Pax6 mutants

60 tion factors (Hox(s), Gata3, Meis1, Eya1 and Pbx1), and enforced their active gene transcription in m

61 pre-B-cell leukemia transcription factor 1 (Pbx1), and identified a range of previously undetected d

62 4 methyltransferase, is required for FOXA1, PBX1, and ER recruitment and activation.

63 onstrate that Gfi1 directly represses HoxA9, Pbx1, and Meis1 during normal myelopoiesis.

64 nscription factors Run1t1, Hlf, Lmo2, Prdm5, Pbx1, and Zfp37 imparts multilineage transplantation pot

65 Pbx1, another Meis1 cofactor, also induces apoptosis; ho

66 ncluded the genetic abnormality t(1;19)(TCF3-PBX1), any CNS involvement at diagnosis, and T-cell immu

67 f Pax6 and further demonstrate that Msx2 and Pbx1 are bona fide direct regulators of early Six3.2 dis

68 Both FRA-1 and PBX1 are required for the mesenchymal changes triggered

69 quence requirements for binding by Meis2 and Pbx1 are variable.

70 In addition, our results identify Pbx1 as a novel regulator of CD4(+) T cell effector func

71 ription whereas overexpression of PBX1 and a PBX1-associated protein, PREP1, enhanced viral transcrip

72 c lesions in childhood ALL: ETV6-RUNX1, TCF3-PBX1, BCR-ABL1, and MLL translocations and trisomies of

73 Our results also show that E2A-PBX1 binding to gene enhancers is dependent on the RUNX1

74 ssues or isolated cells, we further detected PBX1 binding to known regulatory regions of the neuron-s

75 romatin immunoprecipitation assays show that Pbx1 binds to the Hox11 promoter in spleen mesenchymal c

76 E2a/Pbx1 blocks differentiation of primary myeloid progenito

77 Mechanistically, E2A-PBX1 bound promoter regulatory regions and activated the

78 d HoxA9-mediated CYBB-transcription requires Pbx1 but is inhibited by Meis1.

79 Targeted deletion of Pbx1 by retroviral transduction of Cre recombinase into

80 Conversely, targeted depletion of Pbx1 by short hairpin RNA (shRNA) increased expression o

81 revious analysis of the in vivo functions of Pbx1 by targeted mutagenesis in mice has revealed roles

82 s, we identified a de novo missense variant, PBX1:c.551G>C p.R184P, in a patient with tetralogy of Fa

83 Pbx1 can, therefore, alternatively act as an oncogene or

84 nclude that deleterious sequence variants in PBX1 cause intellectual disability and pleiotropic malfo

85 hIP-BIT to find target genes from NOTCH3 and PBX1 ChIP-seq data acquired from MCF-7 breast cancer cel

86 ides the first unbiased profiling of the E2A-PBX1 cistrome in pre-B ALL cells and reveals a previousl

87 nchymal cells and identified components of a Pbx1 complex associated with genes in osteoblasts.

88 ose-dependent pattern regulation in Gli3 and Pbx1 compound mutations, we show that the global and reg

89 E2A and the oncogenic chimera E2A-PBX1 contain three transactivation domains (ADs), with A

90 Here, we show that PBX1 controls a novel transcriptional network required f

91 Pbx1 controls chromatin accessibility to a large number

92 E2a-Pbx1 cooperated with cytokines or activated signaling on

93 mias induced by the chimeric oncoprotein E2a-Pbx1 created by t(1;19) chromosomal translocations.

94 Thus, Pbx1 critically functions at a stage between hematopoiet

95 64, CD304, CD97, CD102, CD99, CD300a, CD130, PBX1, CTNNA1, ITGB7, CD69, CD49f) were differentially ex

96 prenatal smoking and birth weight (on MDS2, PBX1, CYP1A2, VPRBP, WBP1L, CD28, and CDK6 genes), and p

97 Pre-B cell leukemia homeobox 1 (Pbx1)-d is a dominant-negative splice isoform of the gen

98 rate that Sle1a1 MSCs express high levels of Pbx1-d as compared with congenic C57BL/6J (B6) MSCs.

99 The Pbx1-d dominant-negative isoform is more frequent in CD4

100 tested the hypothesis that the expression of Pbx1-d favors MSC differentiation and impairs their immu

101 Our results suggest that Pbx1-d impacts lupus development by regulating effector

102 Transgenic (Tg) expression of Pbx1-d in CD4(+) T cells reproduced the phenotypes of Sl

103 Pbx1-d is associated with the production of autoreactive

104 PBX1-d is expressed more frequently in the CD4(+) T cell

105 xpression of the lupus susceptibility allele Pbx1-d isoform impairs MSC functions, which may contribu

106 Pbx1-d overexpression is sufficient to induce an activat

107 Moreover, Pbx1-d-Tg CD4(+) T cells upregulated the expression of m

108 Pbx1-d-Tg expression also expanded the number of follicu

109 xpression of a novel splice isoform of Pbx1, Pbx1-d.

110 , reducing expression of endogenous Meis2 or Pbx1 decreases p15 gene expression and increases the num

111 Pbx1 deficiency also results in the failure of cardiac O

112 We previously reported that Pbx1 deficiency causes organ growth defects including as

113 s following restoration of its expression in Pbx1-deficient ES cells.

114 ransfer experiments, B-cell development from Pbx1-deficient fetal liver cells was also severely compr

115 ously reported, Pbx1 homozygous mutant mice (Pbx1-/-) develop malformations and hypoplasia or aplasia

116 We show that Pbx1 directly activates Pax3, leading to repression of i

117 Notably, we establish that Pbx1 directly represses Pdgfrb, and demonstrate that dec

118 pt these interactions, destabilize the HOXB1:PBX1:DNA complex, and alter HOXB1 transcriptional activi

119 ns-ETV6-RUNX1 (TEL-AML1), BCR-ABL1, and TCF3-PBX1 (E2A-PBX1)-frequently found in precursor-B-cell acu

120 Prior to death at E15.5, Pbx1(-/-) embryos displayed kidneys that were reduced in

121 Analyses of Pbx and Pbx1;Emx2 compound mutants revealed that Pbx genes share

122 Here, we provide a biochemical basis for Pbx1;Emx2 genetic interaction by showing that Pbx1 and E

123 Pbx1 encodes a TALE homeodomain transcription factor tha

124 PBX1 encodes a three amino acid loop extension (TALE) ho

125 E2A-PBX1 in cell and animal models, the E2A-PBX1-enforced cistrome, the E2A-PBX1 interactome, and re

126 ence further maturation, suggesting that E2a/Pbx1 establishes an early block in pro-T-cell developmen

127 We find that PTBP1 represses Pbx1 exon 7 and the expression of the neuronal Pbx1a iso

128 Loss of Pbx1 expression in neuronally committed neuroblasts in t

129 Pbx1 expression is transcriptionally regulated by Notch3

130 bitor could be partially reversed by ectopic Pbx1 expression.

131 moter (Cd19, Mb1, or Mx1) used to induce E2A-PBX1 expression.

132 Pbx1(f/f) mice were crossed with mice containing Cre rec

133 ic activity of Six1-bound novel enhancers of Pbx1, Fgf8, Dusp6, Vangl2, the hair-cell master regulato

134 NX1 (TEL-AML1), BCR-ABL1, and TCF3-PBX1 (E2A-PBX1)-frequently found in precursor-B-cell acute lymphob

135 Loss of Pbx1 from osteoblast promoters in differentiated osteobl

136 ered mice that conditionally express the E2A-PBX1 fusion oncogene, which results from chromosomal tra

137 s the E2A gene and produces an oncogenic E2A-PBX1 fusion protein.

138 nt machinery as a direct target for the TCF3-PBX1 fusion protein.

139 e t(1;19) chromosomal translocation with E2A-PBX1 fusion, and were less likely to have hyperdiploid b

140 t mediator, cg22638236, was annotated to the PBX1 gene body involved in skeletal patterning and progr

141 at B-lineage ALL with either TEL-AML1 or E2A-PBX1 gene fusion, or T-lineage ALL, accumulates signific

142 ically deregulated after ETV6-RUNX1 and TCF3-PBX1 gene fusions, respectively.

143 e novo, deleterious sequence variants in the PBX1 gene.

144 pre-B-cell leukemia transcription factor 1 (Pbx1) gene, down-regulated by CDKI treatment.

145 g functions in shoulder development and that Pbx1 genetically interacts with Emx2 in this process.

146 ol spleen development via separate pathways, Pbx1 genetically regulates key players in both pathways,

147 eduction or absence of Pbx2 or Pbx3 leads to Pbx1 haploinsufficiency and specific malformations that

148 l lines, and no transforming function of E2a/Pbx1 has been reported in cultured lymphoid progenitors.

149 The TALE homeoprotein Pbx1 has been shown to be essential for proximal limb de

150 luded missense substitutions adjacent to the PBX1 homeodomain (p.Arg184Pro, p.Met224Lys, and p.Arg227

151 the DNA-binding activity harbored within the PBX1 homeodomain of E2A-PBX1.

152 The PBX1 homeodomain transcription factor is converted by t(

153 n of E2A-PBX1, through a region spanning the PBX1 homeodomain, with RUNX1.

154 r cells, are absent in the splenic anlage of Pbx1 homozygous mutant (-/-) embryos, implicating the TA

155 As previously reported, Pbx1 homozygous mutant mice (Pbx1-/-) develop malformati

156 Pbx1 homozygous mutants exhibited delayed or absent form

157 ic mice mutant for the transcription factors Pbx1, Hox11 (Tlx1), Nkx3.2 (Bapx1) and Pod1 (capsulin, T

158 These studies establish a Pbx1-Hox11-dependent genetic and transcriptional pathway

159 Expression of Pbx1 impaired osteogenic commitment of C3H10T1/2 multipo

160 Somatic activation of E2A-PBX1 in B cell progenitors enhanced self-renewal and led

161 es have shown the oncogenic functions of E2A-PBX1 in cell and animal models, the E2A-PBX1-enforced ci

162 tudies have demonstrated a critical role for Pbx1 in cellular proliferation and patterning and sugges

163 iation, suggesting an important function for Pbx1 in determining corneal identity.

164 division, as inactivation of conditional E2a/Pbx1 in either factor-dependent pro-T cells or pro-T cel

165 Our results establish an essential role for Pbx1 in genetic interactions with its family members and

166 en together, these data establish a role for Pbx1 in mesenchymal-epithelial signaling and demonstrate

167 Despite the restricted expression of Pbx1 in metanephric mesenchyme, developing nephrons, and

168 n studies have suggested a possible role for Pbx1 in pharyngeal region development.

169 ribe remodeling of signaling networks by E2A-PBX1 in pre-B-ALL, which results in hyperactivation of t

170 Conditional inactivation of Pbx1 in pro-B (CD19(+)) cells and thereafter revealed th

171 al ablation of the TALE transcription factor Pbx1 in renal VMC progenitors in the mouse led to the pr

172 ) embryos, implicating the TALE homeoprotein Pbx1 in splenic cell specification.

173 , we identify the direct target sites of E2A-PBX1 in t(1,19)-positive pre-B ALL cells and show that,

174 Tissue-specific deletion of Pbx1 in the corneal epithelium of mice resulted in corne

175 e investigated the potential requirement for Pbx1 in the development of the pharyngeal arches and pou

176 Expression of the PBC protein PBX1 in the SVZ has been reported, but its functional ro

177 w that mice with splenic mesenchyme-specific Pbx1 inactivation exhibit hyposplenia.

178 we identify HoxA10 amino acids 224-249 as a Pbx1-independent repression domain, which interacts with

179 functions of Hox proteins in this region are Pbx1-independent.

180 cus itself is also directly activated by E2A-PBX1, indicating a multilayered interplay between E2A-PB

181 interaction as a therapeutic target for E2A-PBX1-induced leukemia.

182 Here, we demonstrate that E2a/Pbx1 induces immortal proliferation of stem cell factor

183 emia homeobox interacting protein 1 or human PBX1 interacting protein (PBXIP1/HPIP) is a co-repressor

184 els, the E2A-PBX1-enforced cistrome, the E2A-PBX1 interactome, and related mechanisms underlying leuk

185 at normally stabilize and regulate import of PBX1 into the nucleus, but the mechanisms underlying its

186 n together, the above findings indicate that Pbx1 is a direct Notch3-regulated gene that mediates the

187 These findings indicate that Pbx1 is a novel lupus susceptibility gene that regulates

188 Pbx1 is a TALE-class homeodomain protein that functions

189 ss-of-function mouse model, we now show that Pbx1 is an early regulator of SVZ neurogenesis.

190 al-epithelial signaling and demonstrate that Pbx1 is an essential regulator of mesenchymal function d

191 Our results show that Pbx1 is associated with histone deacetylases normally li

192 y inactive genes: In undifferentiated cells, PBX1 is bound to the H1-compacted promoter/proximal enha

193 y Pbx1 short hairpin RNA knockdown show that Pbx1 is essential for cell proliferation and tumorigenic

194 Finally, Pbx1 is expressed in GnRH neurons in embryonic as well a

195 These findings suggest that PBX1 is involved in monogenic CAKUT in humans and call i

196 (CD19(+)) cells and thereafter revealed that Pbx1 is not necessary for B-cell development to proceed

197 Oncoprotein E2a/Pbx1 is produced by the t(1;19) chromosomal translocatio

198 Pbx1 is required to maintain stem cell self-renewal, inc

199 Pre-B cell leukemia factor 1 (PBX1) is an essential developmental transcription factor

200 nduction of tubulogenic mesenchyme; however, Pbx1(-/-) kidneys contained fewer nephrons and were char

201 the lymphoid versus myeloid character of E2a/Pbx1 leukemia and may cooperate with E2a/Pbx1 to dictate

202 example, whereas the E2A portion of the E2A-Pbx1 leukemia fusion protein mediates robust transcripti

203 ation of mouse and human ALLs, including E2A-PBX1 leukemias, and increased disease-free survival afte

204 oliferation of human and mouse preBCR(+)/E2A-PBX1(+) leukemias in vitro and in vivo Furthermore, comb

205 Thus, Pbx1 makes a crucial contribution to distinct regulatory

206 ia (ALL) and four ALL subtypes: BCR-ABL, E2A-PBX1, MALL and TALL.

207 es, HES-5, HEY-1, c-Myc, Deltex-1, NRARP and PBX1, markedly increased in MARY-X.

208 lish a significant RUNX1 requirement for E2A-PBX1-mediated target gene activation and leukemogenesis.

209 of HoxA9, Pbx1 and Meis1, exaggerated HoxA9-Pbx1-Meis1 activity, and progenitor transformation in co

210 differentiation; the suppression of a HoxA9-Pbx1-Meis1 progenitor program and the induction of a gra

211 These data support conditional E2A-PBX1 mice as a model of human ALL and suggest targeting

212 program of SVZ neurogenesis, suggesting that PBX1 might act as a priming factor to mark these genes f

213 to be limited to few ALL subtypes (e.g. TCF3-PBX1), most mature B-cell lymphomas rely on BCR signalin

214 leiotropic malformations resembling those in Pbx1 mutant mice, arguing for strong conservation of gen

215 However, some aspects of the Pbx1 mutant phenotype included specific defects that wer

216 that decreased Pdgfrb dosage in conditional Pbx1 mutants substantially rescues vascular patterning d

217 Here we have established that Pbx1 negatively regulates Hoxa10-mediated gene transcrip

218 complementation assays, we demonstrate that Pbx1 null embryonic stem (ES) cells fail to generate com

219 Pbx1-null embryos display anomalous great arteries owing

220 Compound Msx2/Pbx1-null embryos display significant rescue of cardiac

221 Pbx1-null embryos lose a transient burst of Pax3 express

222 the great-artery anomalies of compound Msx2/Pbx1-null embryos remain within the same spectrum as tho

223 remain within the same spectrum as those of Pbx1-null embryos.

224 thway partially underlies the OFT defects in Pbx1-null mice.

225 Furthermore, the adverse effects of E2a-Pbx1 on pre-B cell survival and differentiation are part

226 nique dependence on self-association for E2A-PBX1 oncogenic activity suggests potential approaches fo

227 on 1;19 and consequent expression of the E2A-PBX1 oncoprotein.

228 ions in acute leukemia into the chimeric E2A-PBX1 oncoprotein.

229 [T-ALL] and B cell ALL [B-ALL] with the TCF3-PBX1 or ETV6-RUNX1 fusions), and 2 subtypes had higher M

230 Here we show that it is PBX3, but not PBX1 or PBX2, that is consistently coexpressed with HOXA

231 own chromosomal translocations (t(1;19)(TCF3-PBX1) or MLL), and 6 of which lacked any previously know

232 te that the homeodomain transcription factor Pbx1 orchestrates separate transcriptional pathways to c

233 ation, demonstrating that disruption of this Pbx1-Pax3-Msx2 regulatory pathway partially underlies th

234 re that E2A-PBX1 self-associates through the PBX1 PBC-B domain of the chimeric protein to form higher

235 ased expression of a novel splice isoform of Pbx1, Pbx1-d.

236 Pbx2-deficient (Pbx2(-/-)) embryos, compound Pbx1(-/-); Pbx2(+/-) mutants, in addition to their exace

237 Additionally, we reveal that Pbx1(-/-); Pbx2(-/-) embryos lack limbs altogether.

238 ulator of superstructure patterning, whereas Pbx1, Pbx2, Hoxa11 and Hoxd11 act as proximal and distal

239 In this study, we uncover that Pbx1/Pbx2 are co-expressed during successive stages of v

240 s, in vertebrates, distal limb patterning is Pbx1/Pbx2 dependent.

241 posterior limb and regulating ZPA function, Pbx1/Pbx2 exert a primary hierarchical function on Hox g

242 By exploiting a Pbx1/Pbx2 loss-of-function mouse model, we demonstrate t

243 Next, by exploiting a Pbx1/Pbx2 loss-of-function mouse, we show that decreasin

244 Pbx1/Pbx2 mutants exhibit a homogeneous vertebral column

245 ulators of notochord signaling are normal in Pbx1/Pbx2 mutants.

246 ing and hindlimb positioning are governed by Pbx1/Pbx2 through their genetic control of Polycomb and

247 ts show how the oncogenic fusion protein E2A-PBX1 perturbs signaling pathways upstream of PLCgamma2 a

248 We propose that Pbx1 plays a central role in attenuating the ability of

249 Mechanistically, PBX1 plays a dual role in transcription by directly repr

250 3-HLF-positive and treatment-responsive TCF3-PBX1-positive ALL.

251 ATA4 (GATA-binding protein 4) homeobox genes PBX1 (pre-B-cell leukemia transcription factor 1) and ME

252 and show that, compared with normal E2A, E2A-PBX1 preferentially binds to a subset of gene loci cobou

253 g with the stabilization and accumulation of PBX1, PREP1 induces the expression of multiple activator

254 The interaction between the PCE and PBX1-PREP1 proteins was confirmed by gel shift experimen

255 Infusion of E2a/Pbx1 pro-T cells in mice caused T lymphoblastic leukemia

256 In an E2a/Pbx1 pro-T thymocyte clone that induced only pro-T acute

257 h3/CSL protein complex directly binds to the Pbx1 promoter segment harboring the CSL-binding sequence

258 cripts are higher in homozygotes, amounts of PBX1 protein are significantly decreased.

259 In contrast to self-association, PBX1 protein domains that mediate interactions with HOX

260 PBX1 protein is expressed throughout murine embryonic de

261 Blocking PBX1 protein synthesis resulted in a significant decreas

262 gesting abnormal interactions between mutant PBX1 proteins and wild-type TALE or HOX cofactors.

263 r262Glnfs*2, and p.Arg288* yielded truncated PBX1 proteins.

264 e studies establish an essential role of the Pbx1 proto-oncogene in corneal morphogenesis.

265 nduced, MEIS associates with chromatin-bound PBX1, recruits PARP1/ARTD1, and initiates PARP1-mediated

266 Collectively, our results establish that PBX1 regulates adult neural cell fate determination in a

267 Whereas genetic studies indicate that Pbx1 regulates the development and function of insulin-p

268 T-cell quiescence, while reactivation of E2a/Pbx1 restored cell division.

269 Four further associations at or close to the PBX1, RORalpha, NTN1, and SYT6 loci also came close to g

270 We demonstrate here that E2A-PBX1 self-associates through the PBX1 PBC-B domain of th

271 Functional studies on five PBX1 sequence variants revealed perturbation of intrinsi

272 Furthermore, functional studies by Pbx1 short hairpin RNA knockdown show that Pbx1 is essen

273 progenitor cells carrying floxed alleles of Pbx1 significantly reduced the production of neurons and

274 ) in P19 cells using both PBX1b-AS cells and PBX1 small interfering RNA.

275 Removal of p15Ink4b in Pbx1 spleen-specific mutants partially rescues spleen gr

276 protein interactions that otherwise modulate PBX1 stability, nuclear localization, DNA binding, and t

277 y was performed to elucidate the role of the Pbx1 TALE protein in the corneal epithelium of mice.

278 tations directly affect the transcription of PBX1 target genes to impact embryonic development.

279 nal transcriptional activation domain of E2A-PBX1, termed the PCET motif, which has previously been i

280 tion site 1 (Meis1) forms a heterodimer with Pbx1 that augments Hox-dependent gene expression and is

281 dominant-negative splice isoform of the gene Pbx1 that corresponds to the NZM2410 lupus susceptibilit

282 nslocation resulting in a fusion protein E2A-Pbx1 that promotes transformation and leukemogenesis.

283 further document a direct interaction of E2A-PBX1, through a region spanning the PBX1 homeodomain, wi

284 D1 with HEB-AD1 abolished the ability of E2A-Pbx1 to activate target genes and to induce cell transfo

285 E2a/Pbx1 leukemia and may cooperate with E2a/Pbx1 to dictate the pre-B-cell phenotype of human leukem

286 f-association facilitates the binding of E2A-PBX1 to DNA.

287 onditional Pax5 deletion cooperated with E2A-PBX1 to expand progenitor B cell subpopulations, increas

288 ompensate for the inability of monomeric E2A-PBX1 to stably bind DNA and circumvents protein interact

289 Thus, PTBP1 controls the activity of Pbx1 to suppress its neuronal transcriptional program pr

290 on and protein levels revealed that although Pbx1 transcripts are higher in homozygotes, amounts of P

291 All cell lines and primary blasts with E2A-PBX1 translocation and a portion of patients with other

292 ted the first functional model of a missense PBX1 variant and provided strong evidence that p.R184P i

293 enotypic spectrum associated with pathogenic PBX1 variants in both humans and mice.

294 A critical role for Pbx1 was confirmed by rescue of B-cell development from

295 We observed that the homeodomain factor Pbx1, which cooperates with MyoD to stimulate myogenin e

296 bx2 is expressed throughout the limb, unlike Pbx1, which is expressed only in the proximal bud.

297 leukemias expressing the fusion protein E2A-PBX1, which is present in 5%-7% of pediatric and 50% of

298 A major role is served by Pbx1, whose inactivation results in persistent truncus a

299 These results link E2a-Pbx1 with Bmi-1 on an oncogenic pathway that is likely t

300 monstrate using conditional mutagenesis that Pbx1, with and without Pbx2(+/-) sensitization, regulate